Lipid nanoparticles (LNPs) are tiny particles made from lipids that help deliver pharmaceutical drugs, particularly mRNA in COVID-19 vaccines. This summary highlights issues surrounding LNPs in vaccines such as Pfizer-BioNTech and Moderna.
• The quantity of LNPs in a single dose of vaccines is unknown; Moderna stated it's "irrelevant" and no response has been given by the UK’s drug regulator.
• Potential risks of LNPs include systemic toxicity, inflammation, metabolic dysfunction, and long-term effects like neurodegeneration or autoimmune reactions.
• Concerns have been raised by the World Council for Health about billions receiving a poorly characterized delivery system, indicating emerging issues after vaccination.
• There are alarming discoveries regarding impurities in LNPs, including oxidized lipids which can cause inflammation and cellular disruption.
• A study found that synthetic lipids can linger in the body for days after vaccination, often at unusual levels.
• Research suggests that oxidized lipids in LNPs may lead to significant cellular damage and escalate health issues over time.
The long-term consequences of LNPs in vaccines remain uncertain, with calls for better transparency from manufacturers and regulators. Ongoing monitoring and studies are essential to assess the body's response to these compounds. Those concerned about potential toxicity from mRNA vaccines are encouraged to take measures for wellness and consider participating in support initiatives.
https://expose-news.com/2025/06/02/lnps-in-covid-injections/
No comments:
Post a Comment